The Moat Index
Compare moats, side by side.
Two to four companies, scored on the same five investor questions from their SEC filings — so the comparison is apples to apples. The method is fully public.
OMER · Healthcare · No moat
Doesn't clear the bar
The businessTrend component abstained: Fewer than two aligned fiscal years of revenue and diluted EPS are available; the filing history does not contain a measurable trend. The other four 20% weights were renormalized over the scored 80%.
| Measure | CELZ | OMER | PLUR | BDX |
|---|---|---|---|---|
| Moat Score (0–100) | 38 (highest) | 38 (highest) | 38 (highest) | 38 (highest) |
| Methodology version | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 |
| Business trend | 20 | — | 65 (highest) | 49 |
| Pricing power | 70 | 100 (highest) | 72 | 76 |
| Returns on capital | 0 (highest) | 0 (highest) | 0 (highest) | 0 (highest) |
| Balance-sheet safety | 55 (highest) | 28 | 28 | 10 |
| Capital allocation | 44 | 24 | 24 | 54 (highest) |
| No price data | No price data | No price data | 57% above value if growth stopped today | |
| Market cap | $2.7M | $1.2B | $10.1M | $54.7B |
| Moat tier | No moat | No moat | No moat | No moat |
| Filing date | FY2025 | FY2025 | FY2026 | FY2025 |